The Children’s Tumor Foundation is dedicated to funding & driving innovative research that will re
Location: United States, New York
Employees: 51-200
Founded date: 1978
Mentions in press and media 16
| Date | Title | Description |
| 08.08.2024 | Healx Secures $47 Million to Tackle Rare Diseases with AI Innovations | In a significant leap for the biotech sector, Healx, a clinical-stage company based in Cambridge, UK, has successfully raised $47 million in a Series C funding round. This infusion of capital is not just a financial boost; it’s a lifeline f... |
| 07.08.2024 | Healx: Clinical-Stage Biotech Company Secures $47 Million In Series C | Healx, an AI-enabled, clinical-stage biotech company specializing in rare diseases, announced it has raised $47 million in a Series C round. This Series C round was co-led by Silicon Valley-based R42 Group and Atomico, one of Europe’s large... |
| 02.08.2024 | Healx announces $47 million Series C financing and FDA clearance of phase 2 IND for Neurofibromatosis type 1 trial | Cambridge, UK – Healx, an AI-enabled, clinical-stage biotech company specialising in rare diseases, announced it has raised $47 million in a Series C round. Series C round co-led by R42 Group and Atomico, and joined by new/current investors... |
| 11.04.2024 | Healx to receive investment from Children’s Tumor Foundation to advance Neurofibromatosis Type 1 treatments | Cambridge, UK - Healx, the AI-powered, patient-inspired, techbio company pioneering the next generation of drug discovery, announces that it has signed an investment agreement with its long-term partner, Children’s Tumor Foundation (CTF). M... |
| 01.05.2023 | Children's Tumor Foundation Announces Start of NF Awareness Month with Make NF Visible Campaign | 31 Days to Make NF Visible, get involved, and drive research for rare genetic condition that affects millions people worldwide and has no cure NEW YORK, May 1, 2023 /PRNewswire/ -- May is NF Awareness Month and the Children's Tumor Foundati... |
| 10.01.2023 | Children’s Tumor Foundation Expands into a New Strategic Chapter as Impact Investor in NF Research | Topical MEK inhibitor NFX-179 Shows Promise in Shrinking Cutaneous Neurofibromas in NF1 Patients NEW YORK (PRWEB) January 10, 2023 The Children’s Tumor Foundation (CTF) entered a new phase in its strategic NF research model by announcing a ... |
| 26.12.2022 | Gabriel Groisman Elected Chairman of the Board of the Children’s Tumor Foundation | Gabriel Groisman Everyone involved with the Children's Tumor Foundation are the most incredible and passionate people you’ll ever meet, and together we are absolutely determined to find treatments and cures for NF. Patients with NF are figh... |
| 26.12.2022 | Gabriel Groisman Elected Chairman of the Board of the Children's Tumor Foundation | The Board of Directors of the Children's Tumor Foundation (CTF) has unanimously elected Gabriel Groisman of Bal Harbour, Florida, as Chairman of the Board. Mr. Groisman is a government affairs consultant and attorney at LSN Partners, LLC in... |
| 17.05.2022 | Children's Tumor Foundation Announces a Record 500 Architectural Icons Around the World to Shine a Light on NF on World NF Awareness Day | Shine a Light on NF | Children's Tumor Foundation “Raising awareness of NF is the critical first step in generating the funding that’s needed for scientific research that will improve the lives of all NF patients. We are grateful to all our... |
| 01.05.2022 | May is NF (Neurofibromatosis) Awareness Month, Announces Children’s Tumor Foundation | "We’re honored to bring these real-life NF stories to the forefront, both so that NF patients receive the care and treatments they deserve, while also inspiring those who are fighting for someone important in their lives." NEW YOR... |
Show more